Zai Lab Limited growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +8.4%
EBITDA: +32.3%
EBIT: +9.6%
EPS: +87.9%
Free cash flow: +45.9%
Operating cash flow: +45.8%

Forward estimates

Revenue: +27.7%
EBITDA: —
EPS: +7.7%

Three-year CAGR

Revenue: +28.9%
EBITDA: +32.5%
EBIT: +20.8%
Net income: +31.7%
EPS: +38.5%
Free cash flow: +42.5%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.